Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 3/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15315668 | 0.96 | TSHR (0.41) | CYP3A4TDP1ALDH1A1THRBALOX15 | |
| SCHEMBL15039680 | 0.91 | CYP3A4 (0.41) | CYP3A4TDP1ALDH1A1THRBALOX15 | |
| SCHEMBL15020227 | 0.91 | CYP3A4 (0.41) | CYP3A4TDP1ALDH1A1THRBALOX15 | |
| SCHEMBL15020225 | 0.91 | CYP3A4 (0.41) | CYP3A4TDP1ALDH1A1THRBALOX15 | |
| SCHEMBL15315667 | 0.83 | ALDH1A1 (0.37) | CYP3A4TDP1ALDH1A1THRBALOX15 | |
| SCHEMBL15020203 | 0.82 | DNM1 (0.32) | DNM1MEN1KMT2A | |
| SCHEMBL15020202 | 0.82 | DNM1 (0.32) | DNM1MEN1KMT2A | |
| SCHEMBL15039491 | 0.82 | DNM1 (0.32) | DNM1MEN1KMT2A | |
| SCHEMBL15019799 | 0.78 | IDO1 (0.40) | CYP3A4TDP1ALDH1A1THRBALOX15 | |
| SCHEMBL15019795 | 0.78 | IDO1 (0.40) | CYP3A4TDP1ALDH1A1THRBALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130269120-A1 | DYE COMPOSITION COMPRISING BENZYL ALCOHOL, A MONOALCOHOL AND A PARTICULAR DIRECT DYE | L'OREAL (FR) | 2013-10-17 | — | — | US | disclosed |
| WO-2012084817-A2 | DYE COMPOSITION COMPRISING BENZYL ALCOHOL, A MONOALCOHOL AND A PARTICULAR DIRECT DYE | L'OREAL (FR) | 2012-06-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130269120-A1 | DYE COMPOSITION COMPRISING BENZYL ALCOHOL, A MONOALCOHOL AND A PARTICULAR DIRECT DYE | ADH1C, ADH1A, ADH5 | CYP3A4 152/4885TDP1 4178/4885ALDH1A1 9/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.